August 5, 2025 - 01:51

Tentative health insurance rates for individual plans in Pennsylvania for 2026 are projected to rise by an average of 19%. This substantial increase marks one of the largest hikes seen in recent years, raising concerns among consumers and small business owners alike.
The proposed rates, which are still subject to approval, reflect the ongoing challenges faced by the healthcare system, including rising medical costs and increased demand for services. For small business group plans, similar trends are expected, potentially straining budgets and impacting employee benefits.
Insurance providers are citing various factors contributing to these increases, including inflation, higher costs of medical care, and the need to ensure adequate coverage for policyholders. As the state prepares for these changes, many residents are urged to review their current health plans and explore available options to mitigate the impact of the anticipated rate hikes.
With the final decision on rates yet to be made, stakeholders are closely monitoring the situation, hoping for a more manageable outcome for all involved.
May 9, 2026 - 22:43
College of Pharmacy & Health Sciences confers 206 degrees - NewsThe Campbell University College of Pharmacy & Health Sciences held its spring commencement ceremony to honor the achievements of the Class of 2026. A total of 206 degrees were conferred during the...
May 9, 2026 - 02:40
California Becomes First State to Offer Free Diapers for Every NewbornCalifornia is set to launch a first-of-its-kind program that will provide free diapers to every newborn in the state. The initiative, which makes California the first state in the country to offer...
May 8, 2026 - 11:45
Maryland ranked high among states for public health preparedness, but could be doing moreMaryland continues to rank among the top states in the nation for its ability to handle public health emergencies, according to a recent analysis by a national health policy organization. The state...
May 7, 2026 - 18:47
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo NordiskThe arrival of the first generic versions of semaglutide in Canada is being watched closely as a potential turning point for Novo Nordisk`s dominance in the global weight-loss and diabetes market....